Abstract
Get full access to this article
View all access options for this article.
References
1.
Keane W.F.
,
Bailie G.R.
,
Boeschoten E.
,
Gokal R.
,
Golper T.A.
,
Holmes C.J.
Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update (Published erratum appears in Perit Dial Int 2000; 20: 828–9). Perit Dial Int 2000 ; 20 : 396 –411 .
2.
Fiscella R.G.
Physical incompatibility of vancomycin and ceftazidime for intravitreal injection (Letter). Arch Ophthalmol 1993 ; 111 : 730 .
3.
Lifshitz T.
,
Lapid–Gortzak R.
,
Finkelman Y.
,
Klemperer I.
Vancomycin and ceftazidime incompatibility upon intravitreal injection (Letter). Br J Ophthalmol 2000 ; 84 : 117 .
4.
Gahart B.L.
Ceftazidime. In: Intravenous medications: a handbook for nurses and allied health professionals, 11th ed. St. Louis, MO : Mosby , 1995 : 136 –8 .
5.
Cairns C.J.
,
Robertson J.
Incompatibility of ceftazidime and vancomycin. Pharm J 1987 ; 238 : 577 .
6.
Trissel L.A.
Vancomycin HCl. In: Handbook on injectable drugs, 11th ed. Bethesda, MD : American Society of Health-System Pharmacists , 2001 : 1273 –85 .
7.
McEvoy G.K.
, ed. AHFS drug information. Bethesda, MD : American Society of Health-System Pharmacists , 1999 .
8.GlaxoSmithKline. Ceptaz (ceftazidime L-arginine formulation) package insert. Research Triangle Park, NC : GlaxoSmithKline , 1998 .
9.
Trissel L.A.
,
Gilbert D.L.
,
Martinez J.F.
Concentration dependency of vancomycin hydrochloride compatibility with beta-lactam antibiotics during simulated Y-site administration. Hosp Pharm 1999 ; 33 : 1515 –22 .
10.
Vaughan L.M.
,
Poon C.Y.
Stability of ceftazidime and vancomycin alone and in combination in heparinized and nonheparinized peritoneal dialysis solution. Ann Pharmacother 1994 ; 28 : 572 –6 .
11.
Stamatakis M.K.
,
Leader W.G.
,
Tracy T.S.
Stability of high-dose vancomycin and ceftazidime in peritoneal dialysis solutions. Am J Health Syst Pharm 1999 ; 56 : 246 –8 .